Corona Remedies Ltd (CORONA) — Announcement | 30 September 2026

30 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

CARE Ratings reaffirms and upgrades Corona Remedies' credit rating

🔄 What Changed

Long-term bank facilities reduced from ₹25.00 crores; Long-term/short-term facilities upgraded to CARE A1+

🔮 What's Next

Rating review to occur at least annually; surveillance may be triggered by non-cooperation

💡 Investor Takeaway

Routine procedural filing with no direct impact on shareholders.

⚠️ Risks

Potential 'ISSUER NOT COOPERATING' label if information is not provided; rating volatility if trigger clauses activate

Corona Remedies Ltd received a credit rating reaffirmation and upgrade from CARE Ratings on September 30, 2026, reducing long-term bank facilities to ₹7.00 crores and upgrading the long-term/short-term facilities to CARE A1+. The rating actions reflect improved financial performance and operational stability, signaling stronger lender confidence. This development may enhance the company's borrowing capacity and market perception, though it does not directly impact current share price or dividend policy. Investors should monitor future rating reviews and disclosures for ongoing risk assessment.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CORONA ✨ Ask AI About This

About Corona Remedies Ltd (CORONA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹12,701.42 CrP/E: 63.8ROE: 26.6%ROCE: 30.1%Div Yield: 0.48%

View full CORONA stock details →

📡 Get AI alerts when CORONA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CORONA — Free

💡 Ask AI about this filing

"How does the revised rating affect Corona Remedies' borrowing costs?""What are the specific terms of the new CARE A1+ rating?""When will the next credit rating review be conducted?"

Ask AI Free →

📊 More CORONA filings

Announcement — 28 September 2026Corona Remedies Ltd announced that its trading window will close on October 1, 2026, remaining shut ...
🔴 Insider Trading — 19 September 2026Sepia Investments Limited, Sage Investment Trust, and Anchor Partners sold 2,485,476; 51,641; and 92...
🔴 Insider Trading — 19 September 2026Sepia Investments Limited, Sage Investment Trust and Anchor Partners sold a combined 2,630,880 share...
🔴 Announcement — 18 September 2026Corona Remedies Ltd announced an analyst and investor meeting scheduled for September 23, 2026 at 2:...
Announcement — 10 September 2026Corona Remedies clarified that recent share volume increases are purely market-driven with no undisc...

See all CORONA filings →

🔥 Also filed on 30 September 2026

NINSYSNINtec Systems LtdAnnouncement SUNFLAGSunflag Iron & Steel Company LtdAnnouncement MOTILALOFSMotilal Oswal Financial Services LtdCorporate Action BANKINDIABank of IndiaAnnouncement 544150KP Green Engineering LtdAnnouncement INOXGREENInox Green Energy Services LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CORONA files new disclosures

Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.